KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeMD (LFMD) Revenue (2016 - 2025)

LifeMD filings provide 14 years of Revenue readings, the most recent being $7.1 million for Q4 2025.

  • On a quarterly basis, Revenue rose 29.03% to $7.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $182.0 million, a 18.5% increase, with the full-year FY2025 number at $194.1 million, up 25.34% from a year prior.
  • Revenue hit $7.1 million in Q4 2025 for LifeMD, down from $60.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $65.7 million in Q1 2025 to a low of $5.5 million in Q4 2024.
  • Median Revenue over the past 5 years was $32.3 million (2022), compared with a mean of $35.0 million.
  • Biggest five-year swings in Revenue: skyrocketed 322.74% in 2021 and later tumbled 87.77% in 2024.
  • LifeMD's Revenue stood at $27.4 million in 2021, then rose by 2.56% to $28.1 million in 2022, then soared by 59.53% to $44.9 million in 2023, then tumbled by 87.77% to $5.5 million in 2024, then increased by 29.03% to $7.1 million in 2025.
  • The last three reported values for Revenue were $7.1 million (Q4 2025), $60.2 million (Q3 2025), and $49.0 million (Q2 2025) per Business Quant data.